Male Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union - UTU Tutkimustietojärjestelmä

A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Male Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union

Tekijät: Hauser R, Skakkebaek NE, Hass U, Toppari J, Juul A, Andersson AM, Kortenkamp A, Heindel JJ, Trasande L

Kustantaja: ENDOCRINE SOC

Julkaisuvuosi: 2015

Journal: Journal of Clinical Endocrinology and Metabolism

Tietokannassa oleva lehden nimi: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lehden akronyymi: J CLIN ENDOCR METAB

Vuosikerta: 100

Numero: 4

Aloitussivu: 1267

Lopetussivu: 1277

Sivujen määrä: 11

ISSN: 0021-972X

eISSN: 1945-7197

DOI: https://doi.org/10.1210/jc.2014-4325

Tiivistelmä

Conclusions: EDCs may contribute substantially to male reproductive disorders and diseases, with nearly (sic)15 billion annual associated costs in the EU. These estimates represent only a few EDCs for which there were sufficient epidemiological studies and those with the highest probability of causation. These public health costs should be considered as the EU contemplates regulatory action on EDCs.